RCC

Pavlos Msaouel, MD, PhDOncology | February 12, 2024
What does the data and overall understanding of VEGF-TKIs tell us about which patients are optimal candidates for tivozanib?
View More
Victoria SochaASCO 2019 | August 29, 2019
Treatment for advanced renal cell carcinoma (aRCC) commonly includes immune-oncology therapies and tyrosine kinase ...
Kerri FitzgeraldOncology | April 24, 2019
The U.S. Food and Drug Administration approved pembrolizumab (Keytruda®) in combination with axitinib (Inlyta®) for ...
Advertisement
Advertisement
Latest News

March 28, 2024